[HTML][HTML] The role of artificial intelligence in macular hole management: A scoping review

D Mikhail, D Milad, F Antaki, K Hammamji… - Survey of …, 2024 - Elsevier
We focus on the utility of artificial intelligence (AI) in the management of macular hole (MH).
Specifically, we examine AI's role in the diagnosis, treatment, and recovery of MH. We report …

[HTML][HTML] Application of Artificial Intelligence Models to Predict the Onset or Recurrence of Neovascular Age-Related Macular Degeneration

FS Sorrentino, M Zeppieri, C Culiersi, A Florido… - Pharmaceuticals, 2024 - mdpi.com
Neovascular age-related macular degeneration (nAMD) is one of the major causes of vision
impairment that affect millions of people worldwide. Early detection of nAMD is crucial …

[HTML][HTML] Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration: results from Fight Retinal Blindness!

GS Reiter, V Mares, O Leingang, P Fuchs… - Canadian Journal of …, 2024 - Elsevier
Objective To investigate the effect of macular fluid volumes (subretinal fluid [SRF],
intraretinal fluid [IRF], and pigment epithelium detachment [PED]) after initial treatment on …

[HTML][HTML] Application of Artificial Intelligence in Ophthalmology: An Updated Comprehensive Review

H Hashemian, T Peto, R Ambrósio Jr… - … of Ophthalmic & …, 2024 - pmc.ncbi.nlm.nih.gov
Artificial intelligence (AI) holds immense promise for transforming ophthalmic care through
automated screening, precision diagnostics, and optimized treatment planning. This paper …

Predicting Visual Acuity Responses to Anti-VEGF Treatment in the Comparison of Age-related Macular Degeneration Treatments Trials Using Machine Learning

RS Chandra, G Ying - Ophthalmology Retina, 2024 - Elsevier
Purpose To evaluate multiple machine learning (ML) models for predicting 2-year visual
acuity (VA) responses to anti–vascular endothelial growth factor (anti-VEGF) treatment in the …

Application of Artificial Intelligence in the Diagnosis, Follow-Up and Prediction of Treatment of Ophthalmic Diseases

J Yu, F Li, M Liu, M Zhang, X Liu - Seminars in Ophthalmology, 2024 - Taylor & Francis
Purpose To describe the application of artificial intelligence (AI) in ophthalmic diseases and
its possible future directions. Methods A retrospective review of the literature from PubMed …

Artificial intelligence in age-related macular degeneration—a review

K Urbańska, P Więsyk, M Woźniak… - Ophthalmology …, 2024 - journals.viamedica.pl
ABSTRACTAge-related macular degeneration (AMD) is a leading cause of blindness
globally, affecting mainly individuals over 55 years old. Diagnosis typically involves dilated …